Back to Dashboard
IM048-022 (EXCALIBER-Maint))
MM
•
IM048-022 (EXCALIBER-Maint))
•
Last updated: 2/17/2026
Recruiting
Study Design
Study Drug
Iberdomide
Mechanism of Action
CUL4-CRBN E3-Bite
Sponsor
Unknown
Design
III
Control Arm
Lenalidomide
Criteria
Inclusion Criteria
after ASCT with NDMM
Age: Phase: III
Exclusion Criteria
Enrollment
Progress
2 / 7
Contact Information
Principal Investigator
Unknown
Study Nurse
曾睦捷
Contact Tel
4620